Peter Meinke

Peter Meinke serves as a Research Group Leader at the Friedrich-Baur-Institut within the Department of Neurology at the Faculty of Medicine, Ludwig Maximilian University of Munich (LMU). As a full member of the Graduate School of Systemic Neurosciences (GSN), he directs research on multisystemic neuromuscular disorders with institutional affiliation at LMU Klinikum.

His research program centers on three interconnected disease categories: repeat expansion disorders (including myotonic dystrophies and facioscapulohumeral muscular dystrophy), nuclear envelope pathologies (such as Emery-Dreifuss myopathy), and glycogen storage diseases (notably Pompe disease). His group employs integrated approaches spanning transcriptomics, bioinformatics, metabolic phenotyping, immunohistochemistry, primary tissue culture, and viral vector systems to investigate molecular pathomechanisms. Key cellular processes under examination include aberrant RNA splicing, metabolic dysregulation, nuclear membrane defects, and accelerated cellular aging in disease contexts, with emphasis on translating findings into therapeutic interventions.

Dr. Meinke actively supervises doctoral candidates through the GSN program, including Hanseul Oh. His laboratory at the Friedrich-Baur-Institut develops advanced cell culture models for therapeutic screening, focusing on neuromuscular and metabolic disease pathways while maintaining strong clinical connections through LMU Klinikum's neurological department.